𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Monitoring minimal residual disease in AML: the right time for real time

✍ Scribed by U. Jaeger; B. Kainz


Publisher
Springer
Year
2003
Tongue
English
Weight
272 KB
Volume
82
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Rapid and sensitive minimal residual dis
✍ Niels Pallisgaard; Niels Clausen; Henrik SchrΓΈder; Peter Hokland πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 353 KB πŸ‘ 2 views

Because previous PCR-based methodologies for detection of minimal residual disease (MRD) in leukemia patients have been too cumbersome to allow for widespread clinical usefulness, we have employed a real-time quantitative PCR (RQ-PCR) system to develop an MRD assay for t(12;21). We initially determi

Quantitation of minimal residual disease
✍ Sugimoto, Takeshi; Das, Hiranmoy; Imoto, Shion; Murayama, Tohru; Gomyo, Hiroshi; πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 104 KB πŸ‘ 2 views

t(8;21) is one of the common chromosomal translocations in acute myelogenous leukemia (AML). Using a recently developed real-time quantitative polymerase chain reaction (PCR) system, we analyzed the minimal residual disease (MRD) in bone marrow samples from seven AML patients with t(8;21) at differe